Skip to content

Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK

A Prospective, Multi Center Clinical Comparison of Fellow Eyes Undergoing Lasik Using the Wavelight Allegretto Wave™ Excimer Laser in One Eye and the Amo/Visx Customvue™ or the Ladarvision 4000 Excimer Laser System in the Contralateral Eye

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00821236
Acronym
WLCVLV-001
Enrollment
40
Registered
2009-01-13
Start date
2009-01-31
Completion date
2010-02-28
Last updated
2013-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Astigmatism

Keywords

Myopia, LASIK, Astigmatism, Laser Vision Correction, Excimer Laser

Brief summary

The purpose of this study is to compare LASIK outcomes using the WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment. Standard refractive outcomes such as uncorrected and best corrected visual acuity, and intended vs. achieved postoperative refractions will be evaluated; in addition, high order optical aberrations, contrast sensitivity, and topography will be measured.

Detailed description

The primary objective of this study is to compare WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment using both subjective and objective outcome measures. This comparison will be made between fellow eyes of the same patient following excimer laser ablation using the WaveLight ALLEGRETTO WAVE™ Excimer Laser System in one eye and the AMO/VISX CustomVue™ or the LADARVision 4000 excimer laser in the contralateral eye .

Interventions

WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment

DEVICEAMO/VISX CustomVue™

Excimer Laser

DEVICELADARVision 4000 excimer laser

Excimer Laser

Sponsors

Alcon Research
CollaboratorINDUSTRY
Durrie Vision
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects who have up to -7.00D of spherical equivalent myopia or myopia with astigmatism, with up to -7.00D of spherical component and up to 3.00 D of astigmatic component at the spectacle plane in both eyes. * Subjects must have a stable refraction as documented by previous clinical records. Spherical equivalent has not progressed at a rate of more than 0.50D per year prior to the baseline examination in both eyes or as documented by clinical judgment by the investigator. * Subjects who wear contact lenses must discontinue wear at least 3 days for soft and at least 3 weeks for RGP prior to the preoperative evaluation or surgery, in either eye. * Subjects must have visual acuity correctable to at least 20/20 in both eyes. * Subjects must be at least 18 years of age. * Subjects must be willing and able to return for scheduled follow up examinations for twelve months after LASIK surgery. * Subjects must sign and be given a copy of the written Informed Consent form.

Exclusion criteria

* Subjects for whom both eyes do not meet all inclusion criteria and either eye meets any

Design outcomes

Primary

MeasureTime frameDescription
1 Day Postoperative Lasik Uncorrected Visual Acuity1 DayVisual acuity measured without glasses or contact lenses. LogMar is a method of measuring visual acuity. Generally speaking, the U.S. population is familiar with 20/20 visual acuity reference. Samples of LogMar equivalent values would be 20/20=0.0 LogMar, 20/25=0.1 LogMar, 20/16=-0.1, etc.
1 Week Postoperative Lasik Uncorrected Visual Acuity1 week post opVisual acuity measured withouth glasses or contact lenses. LogMar is a method of measuring visual acuity. Generally speaking, the U.S. population is familiar with 20/20 visual acuity reference. Samples of LogMar equivalent values would be 20/20=0.0 LogMar, 20/25=0.1 LogMar, 20/16=-0.1, etc.
1 Month Postoperative Lasik Visual Acuity1 Month PostoperativeVisual acuity measured without glasses or contact lenses. LogMar is a method of measuring visual acuity. Generally speaking, the U.S. population is familiar with 20/20 visual acuity reference. Samples of LogMar equivalent values would be 20/20=0.0 LogMar, 20/25=0.1 LogMar, 20/16=-0.1, etc.

Countries

United States

Participant flow

Participants by arm

ArmCount
Wavelight
WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment
20
AMO/VISX CustomVue
AMO/VISX CustomVue™
10
LADARVision 4000 Excimer Laser
LADARVision 4000 excimer laser treatment
10
Total40

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up3

Baseline characteristics

CharacteristicTotalWavelightAMO/VISX CustomVueLADARVision 4000 Excimer Laser
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants20 Participants10 Participants10 Participants
Sex: Female, Male
Female
25 Participants13 Participants6 Participants6 Participants
Sex: Female, Male
Male
15 Participants7 Participants4 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 200 / 100 / 10
serious
Total, serious adverse events
0 / 200 / 100 / 10

Outcome results

Primary

1 Day Postoperative Lasik Uncorrected Visual Acuity

Visual acuity measured without glasses or contact lenses. LogMar is a method of measuring visual acuity. Generally speaking, the U.S. population is familiar with 20/20 visual acuity reference. Samples of LogMar equivalent values would be 20/20=0.0 LogMar, 20/25=0.1 LogMar, 20/16=-0.1, etc.

Time frame: 1 Day

ArmMeasureValue (MEAN)Dispersion
Wavelight1 Day Postoperative Lasik Uncorrected Visual Acuity-0.04 LogMarStandard Deviation 0.08
AMO/VISX CustomVue1 Day Postoperative Lasik Uncorrected Visual Acuity-0.05 LogMarStandard Deviation 0.06
LADARVision 4000 Excimer Laser1 Day Postoperative Lasik Uncorrected Visual Acuity0.06 LogMarStandard Deviation 0.16
Primary

1 Month Postoperative Lasik Visual Acuity

Visual acuity measured without glasses or contact lenses. LogMar is a method of measuring visual acuity. Generally speaking, the U.S. population is familiar with 20/20 visual acuity reference. Samples of LogMar equivalent values would be 20/20=0.0 LogMar, 20/25=0.1 LogMar, 20/16=-0.1, etc.

Time frame: 1 Month Postoperative

ArmMeasureValue (MEAN)Dispersion
Wavelight1 Month Postoperative Lasik Visual Acuity-0.1 LogMarStandard Deviation 0.09
AMO/VISX CustomVue1 Month Postoperative Lasik Visual Acuity-0.11 LogMarStandard Deviation 0.06
LADARVision 4000 Excimer Laser1 Month Postoperative Lasik Visual Acuity0.08 LogMarStandard Deviation -0.08
Primary

1 Week Postoperative Lasik Uncorrected Visual Acuity

Visual acuity measured withouth glasses or contact lenses. LogMar is a method of measuring visual acuity. Generally speaking, the U.S. population is familiar with 20/20 visual acuity reference. Samples of LogMar equivalent values would be 20/20=0.0 LogMar, 20/25=0.1 LogMar, 20/16=-0.1, etc.

Time frame: 1 week post op

ArmMeasureValue (MEAN)Dispersion
Wavelight1 Week Postoperative Lasik Uncorrected Visual Acuity-0.04 LogMarStandard Deviation 5.27
AMO/VISX CustomVue1 Week Postoperative Lasik Uncorrected Visual Acuity-0.09 LogMarStandard Deviation 2.36
LADARVision 4000 Excimer Laser1 Week Postoperative Lasik Uncorrected Visual Acuity-0.02 LogMarStandard Deviation 5.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026